<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="978">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04374591</url>
  </required_header>
  <id_info>
    <org_study_id>Sodium Bicarbonate COVID-19</org_study_id>
    <nct_id>NCT04374591</nct_id>
  </id_info>
  <brief_title>The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia</brief_title>
  <official_title>The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia: A Preliminary Report of Short Term Follow up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To report the possible role of S.B 8.4% in the treatment of COVID-19pneumonia.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">November 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to clinical recovery</measure>
    <time_frame>7 days</time_frame>
    <description>defined as return of body temperature and relief of cough for more than 72 hours measured in days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulmonary recovery status</measure>
    <time_frame>7 days</time_frame>
    <description>assessed by Chest CT defined as exacerbated, unchanged, moderately improved (with less than 50% pneumonia resolved) and significantly improved (with more than 50% pneumonia resolved).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Pneumonia</condition>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Sodium Bicarbonate</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Inhalation of Sodium Bicarbonate 8.4% via nebulizer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Bicarbonate</intervention_name>
    <description>Inhalation of Sodium Bicarbonate 8.4% via nebulizer</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Sodium Bicarbonate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18 years.

          -  Fever ≥ 38º C with upper respiratory tract manifestations, generalized bone ache with
             or without gastrointestinal symptoms as diarrhea.

          -  Chest CT with signs suggestive of COVID-19.

          -  Mild and moderate cases of COVID-19 pneumonia with respiratory and hemodynamic
             stability. - High C reactive protein (CRP).- With or without history of contact with
             index case who is isolated in a governmental hospital assigned for treatment of
             patients proved to have RT-PCR positive test for COVID-19

          -  With or without abnormalities in the total or differential white cell count.

          -  Welling to sign a fully informed consent.

        Exclusion Criteria:

          -  Severe and critical illness with respiratory failure and/ or hemodynamic instability.

          -  CT with pleural effusion with or without lung cavitation.

          -  Other organ failure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammed K Elbadrawy, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chest department Mansoura University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gomhoria Street</name>
      <address>
        <city>Mansoura</city>
        <state>Outside U.S./Canada</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 2, 2020</study_first_submitted>
  <study_first_submitted_qc>May 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2020</study_first_posted>
  <last_update_submitted>October 2, 2020</last_update_submitted>
  <last_update_submitted_qc>October 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

